Roche said it would increase its dividend after its hemophilia injection Hemlibra and multiple sclerosis treatment Ocrevus lifted sales in the first nine months of the year.
Related Posts
Elliott to Launch Proxy Fight at Southwest Airlines
The activist plans to nominate 10 directors to the carrier’s board.
McDonald’s Is Bringing Chicken to the Big Mac
The twist on the flagship sandwich shows how fast-food companies are adding more of the protein to their menus.
For EV Startups, Things Are Going From Bad to Worse
Makers and suppliers of electric cars are dealing with diminishing cash, uneven sales and the prospects of an unfriendly Trump administration.